Related Experiment Video
Updated: Jul 7, 2026
09:49
Isolation and Cannulation of Cerebral Parenchymal Arterioles
Published on: May 23, 2016
Afferent arteriolar dilation to 11, 12-EET analogs involves PP2A activity and Ca2+-activated K+ Channels
John D Imig1, Christiana Dimitropoulou, D Sudarshan Reddy
1Vascular Biology Center, Medical College of Georgia, Augusta, GA 30912, USA. jdimig@mcg.edu
Microcirculation (New York, N.Y. : 1994)
|February 9, 2008
Summary
The epoxygenase metabolite, 11,12-epoxyeicosatrienoic acid (11,12-EET), dilates renal afferent arterioles. This dilation involves increased phosphoprotein phosphatase 2A (PP2A) activity and activation of large-conductance calcium-activated potassium (KCa) channels.
Area of Science:
- Renal Physiology
- Vascular Biology
- Molecular Pharmacology
Background:
- 11,12-epoxyeicosatrienoic acid (11,12-EET) is an epoxygenase metabolite with known renal vascular actions.
- Understanding the signaling mechanisms of 11,12-EET is crucial for investigating afferent arteriolar dilation.
- Development of stable 11,12-EET analogs aids in structure-activity relationship studies and mechanistic investigations.
Purpose of the Study:
- To investigate the role of phosphoprotein phosphatase 2A (PP2A) and large-conductance calcium-activated potassium (KCa) channels in 11,12-EET-mediated afferent arteriolar dilation.
- To evaluate the efficacy of chemically and metabolically stable 11,12-EET analogs in inducing vasodilation.
- To elucidate the signaling pathways involved in the activation of KCa channels by 11,12-EET analogs.
Main Methods:
- Assessment of afferent arteriolar diameter changes in response to 11,12-EET analogs.
- Single-cell channel recordings in renal myocytes to determine KCa channel activation.
- Measurement of intracellular cAMP levels and PP2A activity in renal myocytes.
Main Results:
- 11,12-EET analogs significantly increased afferent arteriolar diameter.
- Vasodilator responses to 11,12-EET analogs were abrogated by PP2A or K+ channel inhibition.
- 11,12-EET analogs activated renal myocyte KCa channels, increased cAMP levels, and augmented PP2A activity.
- PP2A activation of KCa channels was more pronounced than PKA-mediated activation.
Conclusions:
- 11,12-EET mediates afferent arteriolar dilation through a PP2A-dependent pathway.
- Activation of large-conductance KCa channels is a key mechanism in 11,12-EET-induced vasodilation.
- The findings support a model where 11,12-EET utilizes PP2A to activate KCa channels, leading to renal vasodilation.
Related Concept Videos
01:23Antihypertensive Drugs: Vasodilators
Vasodilators, primarily affecting the smooth muscles within arterial and venous walls, are commonly used for hypertension treatment. Medications such as minoxidil and hydralazine primarily target arteries and arterioles, while sodium nitroprusside acts on arterioles and venules. Minoxidil, functioning as a prodrug, is metabolized by hepatic sulfotransferase into its active form, minoxidil sulfate, after oral administration. This metabolite binds to the sulfonylurea receptor (SUR) component of...
01:18Antihypertensive Drugs: Action of Calcium Channel Blockers
Calcium ions are essential to contract smooth muscle cells in blood vessels. They enter these cells through voltage-dependent calcium channels, specifically L-type calcium channels in the cell membrane. These L-type calcium channels are integral to the excitation-contraction coupling process in smooth muscle. When a stimulus is received by smooth muscle cells, their membrane depolarizes. This alteration in membrane potential instigates the opening of L-type calcium channels. As a result,...
01:18Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme (ECE). Of...
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme (ECE). Of...
01:31Adrenergic Receptors: ɑ Subtype
Adrenoceptors are classified into α and ꞵ classes based on their potencies to catecholamine agonists. α-adrenoceptors show the following order of catecholamine potency:
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase C—inositol-1,4,5-trisphosphate...
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase C—inositol-1,4,5-trisphosphate...
00:59Direct-Acting Cholinergic Agonists: Pharmacological Actions
Direct-acting cholinergic agonists exert their pharmacological actions by mimicking the effects of acetylcholine on postsynaptic muscarinic receptors to generate parasympathetic responses. These agents elicit a range of physiological responses, including cardiovascular effects. For example, activation of muscarinic receptors induces bradycardia, decreased cardiac output, reduced peripheral resistance, and consequent hypotension. In the eye, stimulation of M3 receptors leads to smooth muscle...
01:28Nitric Oxide Signaling Pathway
Nitric oxide (NO), an inorganic gas, acts as a potent second messenger in most animal and plant tissues. NO diffuses out of the cells that produce it and enters the neighboring cells to generate a downstream response. NO synthase (NOS) catalyzes NO production by the deamination of the amino acid arginine. There are three isoforms of NOS. Endothelial cells have endothelial NOS (eNOS), nerve and muscle cells have neuronal NOS (nNOS), and macrophages produce inducible NOS (iNOS) upon exposure to...